S
Somnuek Sungkanuparph
Researcher at Mahidol University
Publications - 262
Citations - 7063
Somnuek Sungkanuparph is an academic researcher from Mahidol University. The author has contributed to research in topics: Efavirenz & Nevirapine. The author has an hindex of 42, co-authored 247 publications receiving 6424 citations. Previous affiliations of Somnuek Sungkanuparph include Thailand Ministry of Public Health & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.
Ekawat Pasomsub,Siriorn P. Watcharananan,Kochawan Boonyawat,Pareena Janchompoo,Garanyuta Wongtabtim,Worramin Suksuwan,Somnuek Sungkanuparph,Angsana Phuphuakrat +7 more
TL;DR: Saliva might be an alternative specimen for the diagnosis of COVID-19 if the collection is non-invasive, and non-aerosol generating, given the simplicity of specimen collection and good diagnostic performance.
Journal ArticleDOI
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
Lewis J. Haddow,Lewis J. Haddow,Robert Colebunders,Robert Colebunders,Graeme Meintjes,Stephen D. Lawn,Stephen D. Lawn,Julian Elliott,Julian Elliott,Yukari C. Manabe,Yukari C. Manabe,Paul R. Bohjanen,Somnuek Sungkanuparph,Philippa Easterbrook,Philippa Easterbrook,Martyn A. French,Martyn A. French,David R. Boulware +17 more
TL;DR: A consensus case definition for paradoxical crytopcoccal IRIS in patients with HIV-1 and known cryptococcal disease before ART, and a separate definition for incident cryptococosis developed during ART (termed ART-associated cryptococcosis) were developed in this article.
Journal ArticleDOI
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.
Weerawat Manosuthi,Suthat Chottanapand,Supeda Thongyen,Achara Chaovavanich,Somnuek Sungkanuparph +4 more
TL;DR: Antiretroviral therapy substantially reduces mortality rate among HIV/TB-coinfected patients and Initiation of ART within 6 months of TB diagnosis is associated with greater survival.
Journal ArticleDOI
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Soo-Yon Rhee,José Luis Santiago Blanco,Michael R. Jordan,Jonathan Taylor,Philippe Lemey,Vici Varghese,Raph L. Hamers,Silvia Bertagnolio,Tobias F. Rinke de Wit,Avelin F. Aghokeng,Jan Albert,Radko Avi,Santiago Ávila-Ríos,Pascal O. Bessong,James Brooks,Charles A. Boucher,Zabrina L. Brumme,Michael P. Busch,Hermann Bussmann,Marie Laure Chaix,Bum Sik Chin,Toni T. D’Aquin,Cillian De Gascun,Anne Derache,Diane Descamps,Alaka Deshpande,Cyrille F. Djoko,Susan H. Eshleman,Hervé Fleury,Pierre Frange,Seiichiro Fujisaki,P. Richard Harrigan,Junko Hattori,África Holguín,Gillian Hunt,Hiroshi Ichimura,Pontiano Kaleebu,David Katzenstein,Sasisopin Kiertiburanakul,Jerome H. Kim,Sung Soon Kim,Yanpeng Li,Irja Lutsar,Lynn Morris,Nicaise Ndembi,Kee Peng Ng,Ramesh S. Paranjape,Martine Peeters,Mario Poljak,Matthew Price,Manon Ragonnet-Cronin,Gustavo Reyes-Terán,Morgane Rolland,Sunee Sirivichayakul,Davey M. Smith,Marcelo A. Soares,Vincent Soriano,Deogratius Ssemwanga,Maja Stanojevic,Mariane A. Stefani,Wataru Sugiura,Somnuek Sungkanuparph,Amilcar Tanuri,Kok Keng Tee,Hong-Ha M. Truong,David A. M. C. van de Vijver,Nicole Vidal,Chunfu Yang,Rongge Yang,Gonzalo Yebra,John P. A. Ioannidis,Anne-Mieke Vandamme,Robert W. Shafer +72 more
TL;DR: Most TDR strains in SSA and SSEA arose independently, suggesting that ARV regimens with a high genetic barrier to resistance combined with improved patient adherence may mitigate TDR increases by reducing the generation of new ARV-resistant strains.
Journal ArticleDOI
Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
Somnuek Sungkanuparph,Weerawat Manosuth,Sasisopin Kiertiburanakul,Bucha Piyavong,Noppanath Chumpathat,Wasun Chantratita +5 more
TL;DR: Almost all patients who experienced treatment failure with their first antiretroviral regimen, a fixed-dose combination of stavudine, lamivUDine, and nevirapine, have lamivudine and nonnucleoside reverse-transcriptase inhibitor resistance.